Alternatives to Rivo Health

It prices Ozempic and Zepbound at $1,399 and $1,599, which almost nobody here does. The compounded line is “from” $49 — under a dated sale, and billed every four weeks.

The brand-access marketplace: real FDA-approved pens and oral options with insurance-style navigation — but a required video visit, a 28-day billing cycle, and prices that sit well above the compounded field.

Compounded semaglutide at $99 a month and tirzepatide at $149, with the provider visit, two-day shipping and injection supplies all included — genuinely cheap for what is in the box. The catch is in what 'no subscription, ever' actually means here. Those rates are six-month programs, paid as one payment up front. The shortest commitment on offer is three months at $165 a month, and maintenance afterwards runs $199. There is no month-to-month option at all, so the flexibility the phrase implies is the opposite of what is on sale. It also names no company anywhere — an address in Dallas and a phone number, but no legal entity.

Lean Meds bundles online care with medication when prescribed, but confirm the total commitment and allow at least 72 hours to cancel before renewal. Our August review linked the brand to Trinity HealthCare Supply, the recipient of an FDA warning letter concerning altRx; today’s Terms do not independently re-establish that ownership relationship.

The posted price is half the bill, and the site says so itself. Read live on 26 August 2026, the weight-loss catalog is ten FDA-approved brand listings — Wegovy as a pill and a pen, Zepbound as a vial and a KwikPen, Ozempic in both forms, Mounjaro, and two new oral tablets in the Ozempic Pill and Foundayo — and every single one carries the same footnote: the figure covers medication only, and a membership at $39 for the first month then $149 a month is required and billed separately. So the $149 Wegovy Pill is really about $298 a month and the $299 Zepbound vial is about $448. That membership is not nothing — 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale and named in-house clinicians — but it is $1,788 a year on top of the drug. One oddity to open before you buy: Mounjaro and one of two Zepbound listings are posted at a flat $1,899 a month on the same page as Zepbound vials at $299, and nothing explains the gap. Its FAQ asks whether video visits are required and whether all states are served, but keeps both answers inside collapsed panels, so neither could be verified. It carries two FDA warning letters dated 9 September 2025 over the compounded-semaglutide business it has since left behind entirely.

Compounded semaglutide at $299 and tirzepatide at $399, quoted as a monthly program but sold as a FOUR-WEEK supply — a distinction that costs you an extra cycle roughly every year and is easy to miss because the site itself writes it as per month. The price is reachable without finishing the quiz, but only inside a collapsed FAQ rather than on any pricing page. Prime Health is a platform rather than a practice: it states plainly that it does not provide medical services, with clinicians supplied through the OpenLoop professional corporations, and its own copy still refers in places to the Remedy Meds platform it is built on. It covers every state except Louisiana and backs the program with a stated money-back guarantee tied to losing at least 10% of body weight in four months.

Solaya MD publishes no price anywhere. The homepage, the weight-loss page, the three-question pre-qualifier and the FAQ were each read end to end and not one contains a dollar figure, and the questionnaire asks whether affordability is what matters most to you before saying anything about cost. The only dollar amounts on the entire property sit in the terms, and they are extra charges rather than the price of treatment: $15 for each additional consult or lab interpretation, and $125 for an at-home blood draw. The same terms describe a membership the marketing pages never mention, billed roughly every 28 to 30 days until canceled, with the first payment due the day it starts and non-refundable once paid. Prescription sales are final. What it discloses well is who treats you, naming Bask Health as the platform whose independent clinicians provide care, and it states plainly that compounded medications are not FDA-approved. Both molecules come oral, injectable and micro, and it claims all fifty states while qualifying the claim in the same sentence.

From $149 semaglutide, $179 tirzepatide, one bundled price, flat at every dose, all 50 states and D.C. The price buys four weeks — stated in its own terms — and requires a three-month plan, a condition shown in the funnel but not on the homepage cards. The month-to-month tier sits behind the intake and is not published. FDA screen clean against a passing control.

Both prices came down since our last check — read live on 2026-08-26 the product cards say compounded semaglutide from $99 a month and tirzepatide from $199, against $149 and $224 in mid-August, with microdose versions at $119 and $139 beside them. Still "from", and Medro is unusually candid about what that means: its own FAQ says starting-at pricing "reflects the lowest typical option" and that final cost varies by medication, dose, supply duration, partner pricing, availability and eligibility, while a footnote under the cards calls the pricing "illustrative". Two other things this record used to get wrong. The site does name its operating entity, Medro Health Technologies, Inc., in the Refund Policy, along with its clinical partner Arora Health & Aesthetics in Seattle and its pharmacy partner The Pharmacy Hub in Miami. And it does publish a cancellation policy — one that sits awkwardly against the FAQ, because the FAQ says there is no membership and nothing recurring to cancel while the Refund Policy describes a subscription charged the moment you finish the intake form, needing 72 hours' notice to stop, with no refund on cancellation.